Patricia María Gómez-Cortez
Patricia María Gómez-Cortez has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Arturo Cuauhtémoc Bautista-Morales
Centro de Investigación en Evaluación y Encuestas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México
2 shared publications - José Luis Alcántara-Zamora
Consultor-investigador independiente. Ciudad de México, México.
2 shared publications - Ofelia Poblano-Verástegui
National Institute of Public Health of Mexico, Cuernavaca, Morelos, Mexico
2 shared publications - Pedro Jesús Saturno-Hernández
Cátedra AXA para la Mejora de la Calidad en Servicios de Salud, Centro de Investigación en Evaluación y Encuestas, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, México...
2 shared publications - José de Jesús Vértiz-Ramírez
Centro de Investigación en Evaluación y Encuestas, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, México
1 shared publication - Luis Miguel Gutiérrez-Robledo
Instituto de Investigación en Ciencias Biomédicas (IICB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico
1 shared publication
Latest Publications
- Open Access
- 8 April 2022
- Published by Instituto Nacional de Salud Publica in Salud Pública de México
- Vol. 64 (2) , 179-187
Acreditación de servicios y calidad de la atención a neonatos en hospitales mexicanos
Objective. To compare the quality of care for neonates with neonatal sepsis, intrauterine hypoxia, prematurity and perinatal asphyxia in accredited hospitals (HA) and unaccredited (HNA). Materials and methods. 28 hospitals of the Ministry of Health were evaluated in 11 states in Mexico; the evaluation included infrastructure, equipment and supplies, quality management processes, and clinical quality indicators. LQAS was used, and average fulfillment of criteria and indicators in AH and NAH was estimated. Results. There were significant differences in favor of HA in equipment and supplies and, not significant, in the existence and functioning of hospital committees.There were no consistent or significant differences in compliance with clinical indicators between the AH y NAH. Conclusions. Accreditation for the care of newborns with the selected diagnoses is not associated with differences in the quality of care.
- 8 April 2022
- Published by Instituto Nacional de Salud Publica in Salud Pública de México
- Vol. 64 (2) , 179-187
Open AccessAcreditación de servicios y calidad de la atención a neonatos en hospitales mexicanos
Objective. To compare the quality of care for neonates with neonatal sepsis, intrauterine hypoxia, prematurity and perinatal asphyxia in accredited hospitals (HA) and unaccredited (HNA). Materials and methods. 28 hospitals of the Ministry of Health were evaluated in 11 states in Mexico; the evaluation included infrastructure, equipment and supplies, quality management processes, and clinical quality indicators. LQAS was used, and average fulfillment of criteria and indicators in AH and NAH was estimated. Results. There were significant differences in favor of HA in equipment and supplies and, not significant, in the existence and functioning of hospital committees.There were no consistent or significant differences in compliance with clinical indicators between the AH y NAH. Conclusions. Accreditation for the care of newborns with the selected diagnoses is not associated with differences in the quality of care.
- Open Access
- 22 November 2021
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Revista de Saúde Pública
- Vol. 55, 80
Prescripción potencialmente inapropiada en adultos mayores en México
OBJETIVE: To identify and quantify potentially inappropriate prescribing (prescripción potencialmente inapropiada, PPI) and other drug prescribing problems in public health care services in a population-based study at the three existing levels of complexity in Mexico. Descriptive analysis of the Study on Satisfaction of Users of the Social Protection System in Health 2014–2016, prescription and drug supply section, to obtain the prevalence of PPI in older adults (≥ 65 years), based on Beers, STOPP, Prescrire and BSP listings using AM (older adults) prescription indicators, one for each listing. Most older adults (67%) were prescribed at least one medication, with a mean of 2.7 medications per prescription. The PPI prevalence was 74% according to the BSP criteria, 67% according to the STOPP listing, 59% with the Beer criteria, and 20% with Prescrire. The most frequent PPI prescriptions were NSAIDs, vasodilators and sulfonylureas. The use of PPIs in AM is high in Mexico. The higher prevalence found in this study may reflect the use of a source with population representativeness. The partial use and adaptations of the criteria make difficult comparing the studies; however, the STOPP criteria are the ones with the highest prevalence, as they cover a greater number of drugs and their use is more common in the first level of care.
- 22 November 2021
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Revista de Saúde Pública
- Vol. 55, 80
Open AccessPrescripción potencialmente inapropiada en adultos mayores en México
OBJETIVE: To identify and quantify potentially inappropriate prescribing (prescripción potencialmente inapropiada, PPI) and other drug prescribing problems in public health care services in a population-based study at the three existing levels of complexity in Mexico. Descriptive analysis of the Study on Satisfaction of Users of the Social Protection System in Health 2014–2016, prescription and drug supply section, to obtain the prevalence of PPI in older adults (≥ 65 years), based on Beers, STOPP, Prescrire and BSP listings using AM (older adults) prescription indicators, one for each listing. Most older adults (67%) were prescribed at least one medication, with a mean of 2.7 medications per prescription. The PPI prevalence was 74% according to the BSP criteria, 67% according to the STOPP listing, 59% with the Beer criteria, and 20% with Prescrire. The most frequent PPI prescriptions were NSAIDs, vasodilators and sulfonylureas. The use of PPIs in AM is high in Mexico. The higher prevalence found in this study may reflect the use of a source with population representativeness. The partial use and adaptations of the criteria make difficult comparing the studies; however, the STOPP criteria are the ones with the highest prevalence, as they cover a greater number of drugs and their use is more common in the first level of care.